Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
World Journal of Clinical Oncology|April 3, 2023
Unusual breast metastasis of gastrointestinal stromal tumor: A case report and literature reviewDaria Filonenko, Nikolay Karnaukhov, Gurami Kvetenadze, et al.Biomedical Reports|May 27, 2022
Early biomarkers of nephrotoxicity associated with the use of anti-VEGF drugsNatalia Chebotareva, Katerina Grechukhina, Valerie Mcdonnell, et al.International Journal of Molecular Sciences|March 27, 2025
Deciphering of SOX9 Functions in Pancreatic Cancer CellsKirill Kashkin, Liya Kondratyeva, Eugene Kopantzev, et al.International Journal of Molecular Sciences|October 16, 2024
Tumor Cell Communications as Promising Supramolecular Targets for Cancer Chemotherapy: A Possible StrategyIrina Alekseenko, Lyudmila Zhukova, Liya Kondratyeva, et al.Translational Gastroenterology and Hepatology|February 6, 2024
Cytoreductive surgery in patients with recurrent or metastatic gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of two Russian cancer centersDaria Filonenko, Petr Arkhiri, Maksim Nikulin, et al.Clinical Breast Cancer|November 30, 2021
The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBCChris Twelves, Rupert Bartsch, Noa Efrat Ben-Baruch, et al.Cancers|December 11, 2025
Deriving Real-World Evidence from Non-English Electronic Medical Records in Hormone Receptor-Positive Breast Cancer Using Large Language ModelsDaur Meretukov, Katerina Grechukhina, Vladimir Evdokimov, et al.Frontiers in Oncology|August 12, 2024
The impact of inhalation versus total intravenous anesthesia on the immune status in patients undergoing breast cancer surgery: a double-blind randomized clinical trial (TeMP)Kristina Kadantseva, Valery Subbotin, Roman Akchulpanov, et al.JAMA Oncology|September 25, 2025
600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical TrialFatima Cardoso, William Jacot, Sherko Kuemmel, et al.International Journal of Molecular Sciences|May 13, 2023
The CFTR Gene Germline Heterozygous Pathogenic Variants in Russian Patients with Malignant Neoplasms and Healthy Carriers: 11,800 WGS ResultsMaria Makarova, Marina Nemtsova, Anastasiia Danishevich, et al.Pageof 2